Background: Women diagnosed with breast cancer are more likely than other
cancer patients to use supplements. Despite potential benefits, there is still a lack of
clear data regarding their safety. It is also concerning that physicians are often
insufficiently informed about this, and that awareness of potential interactions with
treatment remains low. Aim: This narrative review aims to (1) evaluate the role of
dietary supplements in managing breast cancer treatment-related side effects and
(2) critically assess the risks associated with supplement use. Methods: We searched
the literature on PubMed, Embase, the Cochrane Library, and Google Scholar for
publications up to May 1, 2025. The research focused on the use of dietary
supplements by adult breast cancer patients during or after their cancer therapy.
We included 22 trials in the review after screening. Results: Certain supplements,
such as ginger and glutamine, might help reduce nausea and gastrointestinal
toxicity caused by chemotherapy. Conversely, numerous supplements—
particularly antioxidants and herbal compounds—have shown worrisome
interactions with treatment, possibly undermining treatment effectiveness.
Although there may be benefits, numerous patients do not receive advice on the
safe use of supplements, and awareness of their risks is often limited. Conclusion:
Dietary supplements may help alleviate some side effects of breast cancer
treatment, but there is a risk of interactions with ongoing therapy. Physicians
should always actively ask patients about supplement intake. There is a need to
develop clear safety guidelines.
Keywords: breast cancer, dietary supplements, side effect management, drugsupplement
interactions
